General
TGA chief says investigations likely to reveal more details about ‘atypical’ blood-clotting death
The head of the Therapeutic Goods Administration says an autopsy and review may reveal further information about a woman’s death from blood clotting likely linked to the AstraZeneca vaccine.
Key points:
- Professor Skerritt said the woman’s death was an “atypical” case
- The TGA said on Friday the fatal blood clotting was likely linked to the AstraZeneca vaccine
- The federal government is asking health authorities to continuously review all vaccines in the wake of the death
The 48-year-old woman from the New South Wales Central Coast had underlying health conditions but died in hospital several days after receiving the vaccine.
She received the AstraZeneca vaccine before authorities changed their advice to say people aged under 50 should…
Continue Reading
-
Business19 hours agoBuy alert! 2 ASX 200 blue-chip shares worth a look now: expert
-
Noosa News23 hours agoEight Incredible Bali Stays That’ll Save You Money Through Concrete Playground Trips
-
Noosa News22 hours agoPotential crocodile sighting at Noosa Spit sparks investigation
-
Noosa News20 hours agoEmpty city land block sells just short of $1.8 million at auction